Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225.3 USD | +1.73% | +1.77% | -12.92% |
09/05 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
08/05 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.92% | 32.81B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
+54.69% | 25B | |
-16.51% | 15.29B | |
-8.27% | 12.93B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+7.34% | 8.98B | |
-7.13% | 8.23B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- UBS Downgrades Biogen to Neutral From Buy, Cuts Price Target to $276 From $311